Virus News and Research

Latest Virus News and Research

New report highlights gaps in cervical cancer awareness in Brazil

With Brazil's National Cancer Institute estimating 17,010 new cases in 2023, cervical cancer is the third leading cause of morbidity among Brazil's female population.

31 Jul 2023

NIH launches and opens enrollment for phase 2 clinical trials to evaluate long COVID treatments

Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months.

31 Jul 2023

Mutational accessibility: A key driver of viral evolution

The influenza (flu) virus is constantly undergoing a process of evolution and adaptation through acquiring new mutations.

29 Jul 2023

Circadian clock gene plays role in memory formation

A gene that plays a key role in regulating how bodies change across the 24-hour day also influences memory formation, allowing mice to consolidate memories better during the day than at night.

28 Jul 2023

New technique revolutionizes protein-ligand interaction studies

Raman spectroscopy - a chemical analysis method that shines monochromatic light onto a sample and records the scattered light that emerges - has caused frustration among biomedical researchers for more than half a century.

28 Jul 2023

New nano-immune magnetic bead developed for efficient SARS-CoV-2 virus detection

A more efficient way to test SARS-CoV-2 Virus was developed recently by a research team led by Professor WANG Junfeng from Hefei Institutes of Physical Science (HFIPS), Chinese Academy of Science (CAS).

28 Jul 2023

Expert warns of the increasing risks of European holidays

As the UKHSA issues new essential health guidance for travellers going abroad, a leading testing expert warns of the increasing risks of European holidays.

28 Jul 2023

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that The Lancet Infectious Diseases published results from the company's OVX836-003 study under the title, "Immunogenicity, safety and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: randomized, double-blind placebo-controlled, Phase 2a trial."

27 Jul 2023

New gene therapy shows promise in reversing chronic pain

Researchers at NYU College of Dentistry's Pain Research Center have developed a gene therapy that treats chronic pain by indirectly regulating a specific sodium ion channel, according to a new study published in the Proceedings of the National Academy of Sciences.

27 Jul 2023

Human-swine influenza A transmission and evolution of variants

A new study of the strain of influenza A responsible for the 2009 H1N1 pandemic - pdm09 - shows that the virus has passed from humans to swine about 370 times since 2009, and subsequent circulation in swine has resulted in the evolution of pdm09 variants that then jumped from swine to humans.

27 Jul 2023

Study provides valuable insights into the UV susceptibility of SARS-CoV-2 omicron variants

The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its new variants has created a need for effective disinfection technologies to protect against harmful pathogens.

27 Jul 2023

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

A group of researchers compared the effects of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers.

27 Jul 2023

Recent progress in infant hepatitis B vaccination efforts in Africa

Researchers report advancements made toward the elimination of mother-to-child transmission of hepatitis B infection.

27 Jul 2023

Study highlights advantages of syphilis self-testing: convenience, privacy, and rapid results

Researchers performed a meta-analysis on the utility of syphilis self-testing (SST).

26 Jul 2023

Uruguay needs to increase cervical cancer screening rates to reduce mortality, report reveals

Research from the Registro Nacional de Cáncer notes that Uruguay has the highest cancer incidence and mortality rates in Latin America. In particular, cervical cancer is the third leading cause of cancer related morbidity among Uruguay's female population.

26 Jul 2023

Drug interferon proven effective to reduce the spread of COVID-19

Results of an innovative clinical trial led by Perth researchers have shown that the drug interferon could help reduce the spread of COVID-19 from a positive person to their household contacts, with the study helping to inform treatment options for a future pandemic.

26 Jul 2023

Third dose COVID-19 booster vaccines offer lasting protection, trial shows

Third dose COVID-19 booster vaccines offer lasting protection after several months, according to the latest results of a nationwide trial.

25 Jul 2023

Widespread vaccination needed to protect adults from serious and moderate COVID-19 disease

An analysis of real-world data from more than 1.2 million patients from health systems in four geographically dispersed states -- Indiana, Oregon, Texas and Utah -- conducted by the U.S. Centers for Disease Control and Prevention's VISION Network, has determined both the number of adults needed to be vaccinated to prevent one COVID-19 associated hospitalization and the number needed to be vaccinated to prevent one COVID-19 associated emergency department (ED) visit.

25 Jul 2023

Brazilian researchers identify new way to stop excessive inflammation in COVID-19

Researchers at the University of São Paulo (USP) in Brazil have identified a new class of molecules capable of stopping the excessive inflammation typical of the severe form of COVID-19 without impairing the immune response to SARS-CoV-2, the virus that causes the disease.

25 Jul 2023

Data from wearable devices could be valuable in public health research

Data harvested from wearable devices and health apps could be valuable in public health research, according to a study.

25 Jul 2023

Previous
1
...
91
92
93
94
95
96
97
...
1553
Next

Virus News and Research

Latest Virus News and Research

New report highlights gaps in cervical cancer awareness in Brazil

NIH launches and opens enrollment for phase 2 clinical trials to evaluate long COVID treatments

Mutational accessibility: A key driver of viral evolution

Circadian clock gene plays role in memory formation

New technique revolutionizes protein-ligand interaction studies

New nano-immune magnetic bead developed for efficient SARS-CoV-2 virus detection

Expert warns of the increasing risks of European holidays

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

New gene therapy shows promise in reversing chronic pain

Human-swine influenza A transmission and evolution of variants

Study provides valuable insights into the UV susceptibility of SARS-CoV-2 omicron variants

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

Recent progress in infant hepatitis B vaccination efforts in Africa

Study highlights advantages of syphilis self-testing: convenience, privacy, and rapid results

Uruguay needs to increase cervical cancer screening rates to reduce mortality, report reveals

Drug interferon proven effective to reduce the spread of COVID-19

Third dose COVID-19 booster vaccines offer lasting protection, trial shows

Widespread vaccination needed to protect adults from serious and moderate COVID-19 disease

Brazilian researchers identify new way to stop excessive inflammation in COVID-19

Data from wearable devices could be valuable in public health research

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in